iData Research thoroughly covers the orthopedic device market, providing in-depth analysis of the trends that are shaping the industry, updates on new and emerging technology, and much more. We not only provide a comprehensive orthopedic industry overview, but we also delve deep into sub-categories such as the extremities market, joint reconstruction market, arthroplasty market and many others.
Companies of all sizes have turned to iData for more than a decade as they look for the information that will help them take the action necessary to help ensure continued profitability.
The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.
This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and
China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluronic
acid viscosupplementation, and bone morphogenic growth factor therapy. In each country,
the different segments are analyzed by units, procedure numbers and average selling price.